Investigation into how manipulated data from the BEAR I Genetics Panel established the linear no-threshold model of cancer risk assessment
Explore the dual role of circHIPK3 in cancer progression and drug resistance, and its potential as a therapeutic target.
Exploring the role of microRNA-223 and KCNQ1OT1 in cancer progression through molecular mechanisms and therapeutic implications
Explore how immunology's paradigm shift is transforming medicine through cancer immunotherapy and beyond. Learn about groundbreaking research and future directions.
Exploring the role of UBE2C in melanoma progression and its potential as a therapeutic target for this aggressive skin cancer.
Explore the biological roles of CDK11 and CDK12 in cell cycle regulation and their crucial functions in tumorigenesis. Discover how these kinases contribute to cancer development and potential therapeutic approaches.
Explore how Skp2 overexpression drives aggressiveness in myxofibrosarcoma and serves as an independent prognostic marker for poor patient outcomes.
Exploring how mycotoxin-induced mitochondrial dysfunction could become an unprecedented weapon against cancer and proliferative disorders.
Explore how cancer hijacks our immune system and the revolutionary immunotherapies that are reclaiming our natural defenses against tumors.
Explore how dietary phytochemicals modulate apoptosis and autophagy in cancer therapy, their mechanisms, sources, and future research directions.